Bivalirudin is associated with improved clinical and economic outcomes in heart failure patients undergoing percutaneous coronary intervention: Results from an observational database-Reference-Cited by-同舟云学术

Bivalirudin is associated with improved clinical and economic outcomes in heart failure patients undergoing percutaneous coronary intervention: Results from an observational database

Published:2015-05-22 Issue:3 Volume:87 Page:363-373
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet. Cardiovasc. Intervent.

Author:

Pinto Duane S.¹,Kohli Payal²,Fan Weihong³,Kirtane Ajay J.⁴,Kociol Robert D.¹,Meduri Christopher¹,Deliargyris Efthymios N.³,Prats Jayne³,Reynolds Matthew R.⁵,Stone Gregg W.⁴,Michael Gibson C.¹

Affiliation:

1. Cardiology Division; Beth Israel Deaconess Medical Center and Harvard Medical School; Boston Massachusetts

2. Cardiology Division; University of California; San Francisco

3. The Medicines Company; Parsippany New Jersey

4. Columbia University Medical Center/New York Presbyterian Hospital and Cardiovascular Research Foundation; New York New York

5. Lahey Clinic; Burlington, MA and Harvard Clinical Research Institute; Boston Massachusetts

Funder

The Medicines Company (Parsippany, NJ)

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ccd.26023/fullpdf

Reference24 articles.

1. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: Observations from the global registry of acute coronary events (GRACE);Steg;Circulation,2004

2. Predictors of major bleeding in acute coronary syndromes: The global registry of acute coronary events (GRACE);Moscucci;Eur Heart J,2003

3. Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: The logistic clinical SYNTAX score;Farooq;Eur Heart J,2012

4. The impact of ejection fraction on outcomes after percutaneous coronary intervention in patients with congestive heart failure: An analysis of the national heart, lung, and blood institute percutaneous transluminal coronary angioplasty registry and dynamic registry;Holper;Am Heart J,2006

5. Adjusting for patient differences in predicting hospital mortality for percutaneous coronary interventions in the clinical outcomes assessment program;Maynard;Am Heart J,2003

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of DCM associated protein alterations of human right and left ventricles;Journal of Proteomics;2021-01

2. Lugar de acceso y tipo de anticoagulante en pacientes con síndrome coronario agudo en clase Killip avanzada o con parada cardiaca extrahospitalaria;Revista Española de Cardiología;2020-11

3. Choice of access site and type of anticoagulant in acute coronary syndromes with advanced Killip class or out-of-hospital cardiac arrest;Revista Española de Cardiología (English Edition);2020-11

4. Drugs That Affect Blood Coagulation, Fibrinolysis and Hemostasis;Side Effects of Drugs Annual;2017

5. Risk guided use of the direct thrombin inhibitor bivalirudin: insights from recent trials and analyses;Journal of Thoracic Disease;2016-09